Organic Chemistry TRIZ Cases

Substituted alkane-core monomers enable refractive index contrast in volume Bragg gratings.

A pyridinium compound enables void-free copper filling in recessed semiconductor structures.

Oxidizing oripavine with peroxy acids yields 14-hydroxymorphinone, bypassing complex multi-step routes from thebaine.

HDAC6 inhibitors target protein quality control defects in dilated cardiomyopathy, restoring ejection fraction.

A fused-ring heterocyclic compound serves as a phosphorescent host in organic light-emitting diodes to enhance electron transport.

A multi-component organic composition with specific energy levels enhances film formation and printing performance for electronic devices.

A biphenyl fluorene polymer backbone tunes interchain spacing to enhance exciton lifetime and device stability in organic light-emitting diodes.

Enteric polyphenol formulations inhibit alpha-synuclein aggregation in the gut, bypassing blood-brain barrier constraints for Parkinson's treatment.

A 2-phenyl-1,3-dioxolane derivative composition targets renal damage pathways to mitigate chronic kidney disease progression.

Sodium sulfate and urea solidify alcohol ethoxylates to reduce foam stability, eliminating spotting in mechanical warewashing.

Near-infrared dyes targeting carbonic anhydrase IX penetrate deep tissue to visualize hypoxic tumors, resolving low signal-to-noise ratios.

Formula I compounds selectively inhibit the ROMK channel, reducing side effects like dyslipidemia while treating hypertension.

Substituted oligoazacarbazole compounds modulate HOMO and LUMO levels to enhance charge delocalization in organic light emitting devices.

Trisazo compounds maintain color strength and location stability during storage, resolving contradictions between printing function and composition stability.

Formula I compounds inhibit Plasmepsin X and IX proteases, countering artemisinin-based drug resistance in malaria treatment.

Organic molecules with non-conjugated bridges enable direct singlet harvesting.

Alpha-oxoacylaminocaprolactam derivatives inhibit cathepsin K with minimal CYP3A4 activity.

Precipitating zinc hydroxide from zinc pyrrolidonecarboxylate solution removes metal impurities, achieving high chemical and optical purity.

A dual cylinder unit squeezes gas hydrate slurry into high-density pellets, replacing complex thermal control systems to enable continuous production.

A copper electroplating bath uses alpha-amino acid and bisepoxide reaction products to deposit photoresist-defined features with substantially uniform surface morphology.

A curative system combining adipic acid dihydrazide with clathrate-encapsulated imidazoline controls curing agent release to stabilize resin formulations.

Pyrido oxazine derivatives inhibit ALK5 to treat pulmonary fibrosis while reducing systemic exposure and adverse events.

One-pot condensation of aminoguanidine and beta-diketones eliminates multi-step synthesis costs while removing organic solvent waste.

Formula I compounds inhibit Pneumovirinae viruses, replacing costly monoclonal antibodies with cost-effective small molecules.

Electrooxidation drives series cyclization of free radicals to synthesize dibenzocycloheptane derivatives with high yields and reduced side reactions.

A hydrotropic composition using cholinium and long-chain carboxylate anions to enhance extraction efficiency in aqueous environments.

Composite host-dopant materials resolve the trade-off between device simplicity and color purity while extending operational lifetime.

A one-pot process synthesizes 1,2,4-oxadiazole benzoic acids using a single solvent system.

Aryloxy alkylamine additives reduce injector fouling in gasoline engines by maintaining stable fuel flow rates.

Sulphonylurea compounds with specific cyclic substituents act as potent NLRP3 inhibitors and insulin secretagogues.

Nitrogen-containing hexagonal rings paired with indolocarbazole moieties create bipolar organic compounds.

Formula I agents block viral entry to prevent cirrhosis progression, addressing limited therapeutic options via segmentation principles.

7-Azaindole derivatives inhibit IKKε and TBK1 kinases via parameter changes, resolving poor effectiveness across cancer types.

Cannabinoid compositions bind to receptors in dental pulp tissue to reduce inflammation and pain while promoting bone regeneration for jaw defects.

A specialized emission-auxiliary layer with optimized HOMO levels manages charge transport in organic light emitting devices.

A test cell integrates thermal and strain sensors to measure photopolymerization responses directly.

Tautomeric 3-oxo-pyridazine structures resolve insufficient metabolic stability in B1 receptor antagonists.

Novel urea derivatives act as antioxidants to protect stem cells from oxidative stress.

Selective crystallization removes isoanastrozole impurities by over 75% to achieve pharmaceutical-grade purity without complex chromatographic equipment.

Aryl or heteroaryl substituted dithiolene metal complexes absorb infrared radiation through electronic transitions within the transition element d-shell.

Ion-activated photolabile compounds release maskable molecules upon light exposure to enable precise calcium ion detection.

Formula I compounds inhibit ASK-1 enzyme activity, reducing inflammation and apoptosis in non-alcoholic fatty liver disease.

Combining HIF-2α and PARP inhibitors overcomes single-agent resistance in clear cell renal cell carcinoma.

Ortho-substituted linker geometry increases triplet energy level, resolving low-efficiency bottleneck in OLED hole transport layers.

Dimeric SMAC mimetics reactivate latent HIV reservoirs via the non-canonical NF-kB pathway, enabling immune clearance of viral populations.